DRD1 and breast carcinoma: DRD1 is a frequently activated target of psychiatric drugs, but we discovered that the low expression of DRD1 was correlated with poor RFS of breast cancer in the above study, so DRD1 might be not involved in the potential tumorigenicity of psychiatric drugs.